Inke
1 known investors
INKE develops and manufactures active pharmaceutical ingredients (APIs), including high-potency APIs and ophthalmic solutions, using chemical synthesis and micronization technologies. It operates two cGMP manufacturing sites with capabilities in crystal engineering, chromatographic purification, and high-containment handling.
Investors · 1
Frequently asked questions
- What does Inke do?
- INKE develops and manufactures active pharmaceutical ingredients (APIs), including high-potency APIs and ophthalmic solutions, using chemical synthesis and micronization technologies. It operates two cGMP manufacturing sites with capabilities in crystal engineering, chromatographic purification, and high-containment handling.
- Who are Inke's investors?
- Inke's investors include Keensight Capital.